These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 8172484

  • 1. [Study of the efficacy and tolerability of oral administration of cibenzoline in the prevention of recurrence of symptomatic atrial fibrillation].
    Medvedowsky JL, Bine-Scheck F, Dambrine P, Domerego JJ, Garnier LF, Labaki F, Piechaczyk P, Rouesnel P, Schenowitz A.
    Ann Cardiol Angeiol (Paris); 1994 Feb; 43(2):89-96. PubMed ID: 8172484
    [Abstract] [Full Text] [Related]

  • 2. [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study].
    Lardoux H, Maison Blanche P, Marchand X, Canler A, Rouesnel P, Bleinc D, Péraudeau P, Scheck F.
    Ann Cardiol Angeiol (Paris); 1996 Oct; 45(8):469-79. PubMed ID: 8952741
    [Abstract] [Full Text] [Related]

  • 3. [Comparative study of cibenzoline and flecainide by oral route for preventing recurrence of paroxysmal atrial tachyarrhythmias].
    Maison-Blanche P, Brembilla-Perrot B, Fauchier JP, Babuty D, Garnier LF, Rouesnel P, Breuillac JC, Funck F, Scheck F, Peraudeau P, Medvedowsky JL.
    Ann Cardiol Angeiol (Paris); 1997 Feb; 46(2):109-16. PubMed ID: 9137677
    [Abstract] [Full Text] [Related]

  • 4. [Value of cibenzoline in the preventive treatment of recurrent atrial arrhythmia].
    Pisapia A, Bine-Scheck F, Schenowitz A, Domerego JJ, Maraud L, Canler A, Labban N, Viart R, Aubry P, Beruben E.
    Ann Cardiol Angeiol (Paris); 1994 Mar; 43(3):143-51. PubMed ID: 7912916
    [Abstract] [Full Text] [Related]

  • 5. [Efficacy of cibenzoline in the termination and long-term prevention of paroxysmal atrial fibrillation: analysis based on the time of onset].
    Komatsu T, Nakamura S, Kimura M, Owada S, Saito E, Kobayashi T, Okumura K.
    J Cardiol; 2001 Feb; 37(2):75-82. PubMed ID: 11255698
    [Abstract] [Full Text] [Related]

  • 6. [Long-term prevention of the recurrence of auricular fibrillation using cibenzoline. Multicenter study apropos of 89 case reports].
    Frances Y, Luccioni R, Delaage M, Donnarel G, Medvedowsky JL, Quiret JC.
    Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():99-103. PubMed ID: 3938266
    [Abstract] [Full Text] [Related]

  • 7. [Electrophysiologic study of cibenzoline in patients with paroxysmal atrial fibrillation with special reference to atrial fibrillation threshold].
    Inoue D, Ishibashi K, Sakai R, Inoue M, Omori I, Asayama J, Nakagawa M.
    Kokyu To Junkan; 1992 Dec; 40(12):1203-8. PubMed ID: 1480832
    [Abstract] [Full Text] [Related]

  • 8. [Combination of oral administration of cibenzoline and digoxin in patients with supraventricular arrhythmia].
    Garnier LF, Bine-Scheck F, Pruvost P, Wanszelbaum H, Arnaud R.
    Ann Cardiol Angeiol (Paris); 1992 Sep; 41(7):411-7. PubMed ID: 1285630
    [Abstract] [Full Text] [Related]

  • 9. [Comparative study of the efficacy and tolerability of 2 modalities of intravenous cibenzoline administration in the reduction of recent spontaneous atrial arrhythmia].
    Hermida JS, Mabo P, Rouesnel P, Scheck F, Canler A, Barthélémy M, Wanszelbaum H.
    Ann Cardiol Angeiol (Paris); 1995 Jan; 44(1):49-55. PubMed ID: 7702357
    [Abstract] [Full Text] [Related]

  • 10. [A randomized double-blind trial comparing cibenzoline and disopyramide in the prevention of recurrences of atrial tachyarrhythmia].
    Piot O, Flammang D, Dambrine P, Cheikel J, Jouannon C, Graux P, Baudouy Y, Bine-Scheck F, Leenhardt A.
    Arch Mal Coeur Vaiss; 1998 Dec; 91(12):1481-6. PubMed ID: 9891831
    [Abstract] [Full Text] [Related]

  • 11. [Effect of cibenzoline on atrial vulnerability and value of electrophysiological methods in the treatment of paroxysmal atrial fibrillation].
    Kühlkamp V, Ickrath O, Seipel L.
    Z Kardiol; 1990 Aug; 79(8):541-6. PubMed ID: 2220012
    [Abstract] [Full Text] [Related]

  • 12. [Relationship between long-term preventive efficacy of cibenzoline and atrial natriuretic peptide in patients with paroxysmal atrial fibrillation].
    Komatsu T, Nakamura S, Kimura M, Owada S, Yomogida K, Kameda K, Oikawa K, Tomita H, Okumura K.
    J Cardiol; 2002 Feb; 39(2):93-9. PubMed ID: 11873440
    [Abstract] [Full Text] [Related]

  • 13. Cibenzoline for symptomatic ventricular arrhythmias: a prospective, randomized, double-blind, placebo controlled trial and a long term open label study.
    Lee MA, Fenster PE, Garcia ZM, Kipps JE, Huang SK.
    Can J Cardiol; 1989 Sep; 5(6):295-8. PubMed ID: 2477130
    [Abstract] [Full Text] [Related]

  • 14. [Comparative study of cibenzoline and flecainide administered via an intravenous route in reducing auricular arrhythmia].
    Metz D, Chapoutot L, Laudinat JM, Ehrhard V, Taupin JM, Chabert JP, Metivet F, Pollet E, Bajolet A.
    Ann Cardiol Angeiol (Paris); 1990 Jan; 39(1):1-6. PubMed ID: 2107784
    [Abstract] [Full Text] [Related]

  • 15. [Injectable and oral cibenzoline in the treatment of supraventricular tachycardia related to intranodal reentry or accessory atrioventricular conduction pathway].
    Fauchier JP, Rouesnel P, Breuillac JC, Cosnay P, Scheck F, Garnier LF.
    Ann Cardiol Angeiol (Paris); 1994 Apr; 43(4):194-203. PubMed ID: 8024234
    [Abstract] [Full Text] [Related]

  • 16. Cibenzoline versus flecainide in the prevention of paroxysmal atrial arrhythmias: a double-blind randomized study.
    Babuty D, D'Hautefeuille B, Scheck F, Mycinsky C, Pruvost P, Peraudeau P.
    J Clin Pharmacol; 1995 May; 35(5):471-7. PubMed ID: 7657846
    [Abstract] [Full Text] [Related]

  • 17. The effect of oral magnesium, alone or as an adjuvant to sotalol, after cardioversion in patients with persistent atrial fibrillation.
    Frick M, Darpö B, Ostergren J, Rosenqvist M.
    Eur Heart J; 2000 Jul; 21(14):1177-85. PubMed ID: 10924301
    [Abstract] [Full Text] [Related]

  • 18. Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial.
    Fetsch T, Bauer P, Engberding R, Koch HP, Lukl J, Meinertz T, Oeff M, Seipel L, Trappe HJ, Treese N, Breithardt G, Prevention of Atrial Fibrillation after Cardioversion Investigators.
    Eur Heart J; 2004 Aug; 25(16):1385-94. PubMed ID: 15302102
    [Abstract] [Full Text] [Related]

  • 19. [Long-term follow-up of right atrial multilinear high-frequency ablation in the treatment of recurrent paroxysmal atrial fibrillation].
    Dierkes S, Hennersdorf MG, Vester EG, Perings C.
    Dtsch Med Wochenschr; 2003 Jan 24; 128(4):130-4. PubMed ID: 12589581
    [Abstract] [Full Text] [Related]

  • 20. Comparative evaluation of effect of valsartan/amlodipine and atenolol/amlodipine combinations on atrial fibrillation recurrence in hypertensive patients with type 2 diabetes mellitus.
    Fogari R, Zoppi A, Mugellini A, Corradi L, Lazzari P, Preti P, Derosa G.
    J Cardiovasc Pharmacol; 2008 Mar 24; 51(3):217-22. PubMed ID: 18356684
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.